Clinical Trial Update: A Safety and Efficacy Study of Different Injections Volumes of Botulinum Toxin Type A, Azzalure, in the Glabellar Lines [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of different injection volumes of Botulinum Toxin Type A (Azzalure) for glabellar lines; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glabellar Frown Lines

Drugs mentioned

• Azzalure

Snippet

Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 4 | Status: COMPLETED